Insider Trading activities of Bioxcel Therapeutics, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Bioxcel Therapeutics, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Bioxcel Therapeutics, Inc. since year 2005. Table 2 shows the detailed insider transactions of Bioxcel Therapeutics, Inc. since 2005. The reporting company's ticker symbol is BTAI. The reporting company's CIK number is 1720893.
The total value of stock buying since 2005 is $101,974.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Bioxcel Therapeutics, Inc. (BTAI).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2018-12 16,202 $82,094 0 $0 0 $0
2018-11 3,950 $19,880 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Bioxcel Therapeutics, Inc. insiders (BTAI)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2018-12-07 Mueller Peter (Director) Buy 7,400 5.00 37,037
2018-12-06 Mueller Peter (Director) Buy 1,395 5.00 6,981
2018-12-04 Mehta Vimal (CEO, President, Secretary) Buy 1,000 5.12 5,120
2018-12-04 Yocca Frank (Chief Scientific Officer) Buy 450 5.20 2,338
2018-12-04 Mueller Peter (Director) Buy 4,007 5.12 20,515
2018-12-03 Mehta Vimal (CEO, President, Secretary) Buy 1,000 5.15 5,150
2018-12-03 Yocca Frank (Chief Scientific Officer) Buy 450 5.23 2,353
2018-12-03 Steinhart Richard I (Chief Financial Officer) Buy 500 5.20 2,600
2018-11-30 Mehta Vimal (CEO, President, Secretary) Buy 1,000 5.12 5,115
2018-11-30 Yocca Frank (Chief Scientific Officer) Buy 450 5.20 2,339
2018-11-30 Steinhart Richard I (Chief Financial Officer) Buy 500 5.00 2,500
2018-11-29 Nandabalan Krishnan (Director) Buy 1,000 4.92 4,915
2018-11-29 Yocca Frank (Chief Scientific Officer) Buy 500 5.02 2,511
2018-11-29 Steinhart Richard I (Chief Financial Officer) Buy 500 5.00 2,500

Insider trading activities including stock purchases, stock sales, and option exercises of BTAI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Bioxcel Therapeutics, Inc. (symbol BTAI, CIK number 1720893) see the Securities and Exchange Commission (SEC) website.